14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 80 days ( 51.44 % )
Last Price $0.675 0 %
High/ Low $0.675 - $0.675 0%
Chg 7 Days N/A $0.675 $0.675
Chg 30 Days N/A $0.675 $0.675
Chg 12 mos -70.00 % $2.25 $0.675
Trend - 3 mos -15.40 % Width: 20.86 %
Trend - 12 mos -52.98 % Width: 978.22 %
Pred. range - 3 mos $0.476 - $0.575 -29.54 % - -14.84 %
Pred. range - 12 mos $0.0625 - $0.674 -90.73 % - -0.0940 %
Short MA avg 3 mos Sell Jun 27, 2022 - 37 days
Long MA avg 3 mos Sell Aug 05, 2022 - 9 days
Short/Long MA avg 3 mos Sell Aug 05, 2022 - 9 days
Short MA avg 12 mos Sell Jul 05, 2022 - 32 days
Long MA avg 12 mos Sell Apr 13, 2022 - 87 days
Short/Long MA avg 12 mos Sell Apr 18, 2022 - 85 days
Pivot Short Sell Jun 22, 2022 - 40 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Recro Pharma

Recro Pharma Recro Pharma, Inc., a specialty pharmaceutical company, engages in developing non-opioid products for the treatment of acute pain. Its lead product candidate includes injectable meloxicam, a development stage product for the treatment of acute post-operative pain. The company also provides Dex-IN, an intranasal formulation of dexmedetomidine in development stage for the treatment of acute peri-procedural pain; Dex-SL, a product for the treatment ... REPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT